Thermo Fisher (NYSE: TMO) insider plans Rule 144 sale of 6,913 common shares

Rhea-AI Filing Summary

A shareholder of Thermo Fisher Scientific has filed a notice of proposed sale of 6,913 shares of common stock under Rule 144. The shares are to be sold through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of $4,131,761.84 at the time of the notice. The filing lists an approximate sale date of 12/01/2025. These shares were acquired on 12/01/2025 through the cash exercise of an option that was originally granted on 02/26/2019. As context, the filing reports 375,708,059 shares of the issuer’s common stock outstanding.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	6913	4131761.84	375708059	12/01/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/01/2025	Option Granted - 02/26/2019	Issuer			6913	12/01/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Thermo Fisher Scientific (TMO) shares are planned to be sold under this Form 144?

The notice covers a proposed sale of 6,913 shares of Thermo Fisher Scientific common stock.

What is the aggregate market value of the Thermo Fisher Scientific (TMO) shares in this planned sale?

The filing reports an aggregate market value of $4,131,761.84 for the 6,913 common shares to be sold.

When are the Thermo Fisher Scientific (TMO) shares expected to be sold?

The filing lists an approximate date of sale of 12/01/2025 for the proposed transaction.

How were the Thermo Fisher Scientific (TMO) shares being sold under Rule 144 acquired?

The shares were acquired on 12/01/2025 through the cash exercise of an option that was originally granted on 02/26/2019 by the issuer.

Which broker is handling the planned sale of Thermo Fisher Scientific (TMO) shares?

The proposed Rule 144 sale will be executed through Fidelity Brokerage Services LLC, with the shares listed on the NYSE.

How many Thermo Fisher Scientific (TMO) shares are reported as outstanding in this notice?

The notice states that there are 375,708,059 shares of Thermo Fisher Scientific common stock outstanding.